Target Gene/Pathway Pathway / Gene
Search results
No. | KEGG PATHWAY On map, Yellow: Drug target, Red: All disease-related | KEGG GENES | KEGG DRUG | DrugBank | Disease ID | ||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Acute myeloid leukemia 💬 18 genes, 37 drugs (DrugBank) and 71 diseases |
KIT [1] KIT 💬Acute myeloid leukemia
|
Imatinib mesylate Imatinib mesylate 💬Acute myeloid leukemia
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||||||||||||||
2 | Acute myeloid leukemia 💬 18 genes, 37 drugs (DrugBank) and 71 diseases |
KIT [1] KIT 💬Acute myeloid leukemia
|
Imatinib Imatinib 💬Acute myeloid leukemia
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||||||||||||||
3 | AGE-RAGE signaling pathway in diabetic complications 💬 28 genes, 55 drugs (DrugBank) and 96 diseases |
VEGFA [1] VEGFA 💬AGE-RAGE signaling pathway in diabetic complications
|
Bevacizumab Bevacizumab 💬AGE-RAGE signaling pathway in diabetic complications
| Bevacizumab | 013 [8] 13, 34, 85, 87, 89, 227, 280, 331 💬3. AGE-RAGE signaling pathway in diabetic complications
|
||||||||||||||||||||||||||||||||||
4 | Axon guidance 💬 22 genes, 26 drugs (DrugBank) and 75 diseases |
ABL1 [1] ABL1 💬Axon guidance
|
Imatinib mesylate Imatinib mesylate 💬Axon guidance
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬4. Axon guidance
|
||||||||||||||||||||||||||||||||||
5 | Axon guidance 💬 22 genes, 26 drugs (DrugBank) and 75 diseases |
ABL1 [1] ABL1 💬Axon guidance
|
Imatinib Imatinib 💬Axon guidance
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬4. Axon guidance
|
||||||||||||||||||||||||||||||||||
6 | Bladder cancer 💬 11 genes, 27 drugs (DrugBank) and 33 diseases |
VEGFA [1] VEGFA 💬Bladder cancer
|
Bevacizumab Bevacizumab 💬Bladder cancer
| Bevacizumab | 013 [8] 13, 34, 85, 87, 89, 227, 280, 331 💬6. Bladder cancer
|
||||||||||||||||||||||||||||||||||
7 | Breast cancer 💬 22 genes, 63 drugs (DrugBank) and 80 diseases |
KIT [1] KIT 💬Breast cancer
|
Imatinib mesylate Imatinib mesylate 💬Breast cancer
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬7. Breast cancer
|
||||||||||||||||||||||||||||||||||
8 | Breast cancer 💬 22 genes, 63 drugs (DrugBank) and 80 diseases |
KIT [1] KIT 💬Breast cancer
|
Imatinib Imatinib 💬Breast cancer
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬7. Breast cancer
|
||||||||||||||||||||||||||||||||||
9 | Calcium signaling pathway 💬 86 genes, 214 drugs (DrugBank) and 143 diseases |
PDGFRA [1] PDGFRA 💬Calcium signaling pathway
|
Imatinib mesylate Imatinib mesylate 💬Calcium signaling pathway
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬9. Calcium signaling pathway
|
||||||||||||||||||||||||||||||||||
10 | Calcium signaling pathway 💬 86 genes, 214 drugs (DrugBank) and 143 diseases |
PDGFRA [1] PDGFRA 💬Calcium signaling pathway
|
Imatinib Imatinib 💬Calcium signaling pathway
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬9. Calcium signaling pathway
|
||||||||||||||||||||||||||||||||||
11 | Calcium signaling pathway 💬 86 genes, 214 drugs (DrugBank) and 143 diseases |
VEGFA [1] VEGFA 💬Calcium signaling pathway
|
Bevacizumab Bevacizumab 💬Calcium signaling pathway
| Bevacizumab | 013 [8] 13, 34, 85, 87, 89, 227, 280, 331 💬11. Calcium signaling pathway
|
||||||||||||||||||||||||||||||||||
12 | Cell cycle 💬 11 genes, 12 drugs (DrugBank) and 25 diseases |
ABL1 [1] ABL1 💬Cell cycle
|
Imatinib mesylate Imatinib mesylate 💬Cell cycle
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬12. Cell cycle
|
||||||||||||||||||||||||||||||||||
13 | Cell cycle 💬 11 genes, 12 drugs (DrugBank) and 25 diseases |
ABL1 [1] ABL1 💬Cell cycle
|
Imatinib Imatinib 💬Cell cycle
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬12. Cell cycle
|
||||||||||||||||||||||||||||||||||
14 | Central carbon metabolism in cancer 💬 19 genes, 37 drugs (DrugBank) and 65 diseases |
KIT [2] KIT, PDGFRA 💬
|
Imatinib mesylate Imatinib mesylate 💬Central carbon metabolism in cancer
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬14. Central carbon metabolism in cancer
|
||||||||||||||||||||||||||||||||||
15 | Central carbon metabolism in cancer 💬 19 genes, 37 drugs (DrugBank) and 65 diseases |
KIT [2] KIT, PDGFRA 💬
|
Imatinib Imatinib 💬Central carbon metabolism in cancer
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬14. Central carbon metabolism in cancer
|
||||||||||||||||||||||||||||||||||
16 | Chemical carcinogenesis - reactive oxygen species 💬 25 genes, 39 drugs (DrugBank) and 51 diseases |
ABL1 [1] ABL1 💬Chemical carcinogenesis - reactive oxygen species
|
Imatinib mesylate Imatinib mesylate 💬Chemical carcinogenesis - reactive oxygen species
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬16. Chemical carcinogenesis - reactive oxygen species
|
||||||||||||||||||||||||||||||||||
17 | Chemical carcinogenesis - reactive oxygen species 💬 25 genes, 39 drugs (DrugBank) and 51 diseases |
ABL1 [1] ABL1 💬Chemical carcinogenesis - reactive oxygen species
|
Imatinib Imatinib 💬Chemical carcinogenesis - reactive oxygen species
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬16. Chemical carcinogenesis - reactive oxygen species
|
||||||||||||||||||||||||||||||||||
18 | Chemical carcinogenesis - reactive oxygen species 💬 25 genes, 39 drugs (DrugBank) and 51 diseases |
VEGFA [1] VEGFA 💬Chemical carcinogenesis - reactive oxygen species
|
Bevacizumab Bevacizumab 💬Chemical carcinogenesis - reactive oxygen species
| Bevacizumab | 013 [8] 13, 34, 85, 87, 89, 227, 280, 331 💬18. Chemical carcinogenesis - reactive oxygen species
|
||||||||||||||||||||||||||||||||||
19 | Chemical carcinogenesis - receptor activation 💬 39 genes, 135 drugs (DrugBank) and 134 diseases |
VEGFA [1] VEGFA 💬Chemical carcinogenesis - receptor activation
|
Bevacizumab Bevacizumab 💬Chemical carcinogenesis - receptor activation
| Bevacizumab | 013 [8] 13, 34, 85, 87, 89, 227, 280, 331 💬19. Chemical carcinogenesis - receptor activation
|
||||||||||||||||||||||||||||||||||
20 | Choline metabolism in cancer 💬 11 genes, 30 drugs (DrugBank) and 61 diseases |
PDGFRA [1] PDGFRA 💬Choline metabolism in cancer
|
Imatinib mesylate Imatinib mesylate 💬Choline metabolism in cancer
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬20. Choline metabolism in cancer
|
||||||||||||||||||||||||||||||||||
21 | Choline metabolism in cancer 💬 11 genes, 30 drugs (DrugBank) and 61 diseases |
PDGFRA [1] PDGFRA 💬Choline metabolism in cancer
|
Imatinib Imatinib 💬Choline metabolism in cancer
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬20. Choline metabolism in cancer
|
||||||||||||||||||||||||||||||||||
22 | Chronic myeloid leukemia 💬 17 genes, 23 drugs (DrugBank) and 36 diseases |
ABL1 [1] ABL1 💬Chronic myeloid leukemia
|
Imatinib mesylate Imatinib mesylate 💬Chronic myeloid leukemia
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬22. Chronic myeloid leukemia
|
||||||||||||||||||||||||||||||||||
23 | Chronic myeloid leukemia 💬 17 genes, 23 drugs (DrugBank) and 36 diseases |
ABL1 [1] ABL1 💬Chronic myeloid leukemia
|
Imatinib Imatinib 💬Chronic myeloid leukemia
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬22. Chronic myeloid leukemia
|
||||||||||||||||||||||||||||||||||
24 | Endocytosis 💬 22 genes, 37 drugs (DrugBank) and 54 diseases |
PDGFRA [1] PDGFRA 💬Endocytosis
|
Imatinib mesylate Imatinib mesylate 💬Endocytosis
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬24. Endocytosis
|
||||||||||||||||||||||||||||||||||
25 | Endocytosis 💬 22 genes, 37 drugs (DrugBank) and 54 diseases |
PDGFRA [1] PDGFRA 💬Endocytosis
|
Imatinib Imatinib 💬Endocytosis
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬24. Endocytosis
|
||||||||||||||||||||||||||||||||||
26 | ErbB signaling pathway 💬 14 genes, 28 drugs (DrugBank) and 62 diseases |
ABL1 [1] ABL1 💬ErbB signaling pathway
|
Imatinib mesylate Imatinib mesylate 💬ErbB signaling pathway
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬26. ErbB signaling pathway
|
||||||||||||||||||||||||||||||||||
27 | ErbB signaling pathway 💬 14 genes, 28 drugs (DrugBank) and 62 diseases |
ABL1 [1] ABL1 💬ErbB signaling pathway
|
Imatinib Imatinib 💬ErbB signaling pathway
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬26. ErbB signaling pathway
|
||||||||||||||||||||||||||||||||||
28 | Fluid shear stress and atherosclerosis 💬 34 genes, 59 drugs (DrugBank) and 93 diseases |
VEGFA [1] VEGFA 💬Fluid shear stress and atherosclerosis
|
Bevacizumab Bevacizumab 💬Fluid shear stress and atherosclerosis
| Bevacizumab | 013 [8] 13, 34, 85, 87, 89, 227, 280, 331 💬28. Fluid shear stress and atherosclerosis
|
||||||||||||||||||||||||||||||||||
29 | Focal adhesion 💬 31 genes, 51 drugs (DrugBank) and 52 diseases |
PDGFRA [1] PDGFRA 💬Focal adhesion
|
Imatinib mesylate Imatinib mesylate 💬Focal adhesion
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬29. Focal adhesion
|
||||||||||||||||||||||||||||||||||
30 | Focal adhesion 💬 31 genes, 51 drugs (DrugBank) and 52 diseases |
PDGFRA [1] PDGFRA 💬Focal adhesion
|
Imatinib Imatinib 💬Focal adhesion
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬29. Focal adhesion
|
||||||||||||||||||||||||||||||||||
31 | Focal adhesion 💬 31 genes, 51 drugs (DrugBank) and 52 diseases |
VEGFA [1] VEGFA 💬Focal adhesion
|
Bevacizumab Bevacizumab 💬Focal adhesion
| Bevacizumab | 013 [8] 13, 34, 85, 87, 89, 227, 280, 331 💬31. Focal adhesion
|
||||||||||||||||||||||||||||||||||
32 | Gap junction 💬 26 genes, 97 drugs (DrugBank) and 82 diseases |
PDGFRA [1] PDGFRA 💬Gap junction
|
Imatinib mesylate Imatinib mesylate 💬Gap junction
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬32. Gap junction
|
||||||||||||||||||||||||||||||||||
33 | Gap junction 💬 26 genes, 97 drugs (DrugBank) and 82 diseases |
PDGFRA [1] PDGFRA 💬Gap junction
|
Imatinib Imatinib 💬Gap junction
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬32. Gap junction
|
||||||||||||||||||||||||||||||||||
34 | Glioma 💬 15 genes, 34 drugs (DrugBank) and 64 diseases |
PDGFRA [1] PDGFRA 💬Glioma
|
Imatinib mesylate Imatinib mesylate 💬Glioma
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬34. Glioma
|
||||||||||||||||||||||||||||||||||
35 | Glioma 💬 15 genes, 34 drugs (DrugBank) and 64 diseases |
PDGFRA [1] PDGFRA 💬Glioma
|
Imatinib Imatinib 💬Glioma
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬34. Glioma
|
||||||||||||||||||||||||||||||||||
36 | Hematopoietic cell lineage 💬 53 genes, 95 drugs (DrugBank) and 101 diseases |
KIT [1] KIT 💬Hematopoietic cell lineage
|
Imatinib mesylate Imatinib mesylate 💬Hematopoietic cell lineage
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬36. Hematopoietic cell lineage
|
||||||||||||||||||||||||||||||||||
37 | Hematopoietic cell lineage 💬 53 genes, 95 drugs (DrugBank) and 101 diseases |
KIT [1] KIT 💬Hematopoietic cell lineage
|
Imatinib Imatinib 💬Hematopoietic cell lineage
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬36. Hematopoietic cell lineage
|
||||||||||||||||||||||||||||||||||
38 | HIF-1 signaling pathway 💬 26 genes, 56 drugs (DrugBank) and 87 diseases |
VEGFA [1] VEGFA 💬HIF-1 signaling pathway
|
Bevacizumab Bevacizumab 💬HIF-1 signaling pathway
| Bevacizumab | 013 [8] 13, 34, 85, 87, 89, 227, 280, 331 💬38. HIF-1 signaling pathway
|
||||||||||||||||||||||||||||||||||
39 | Human cytomegalovirus infection 💬 64 genes, 114 drugs (DrugBank) and 130 diseases |
PDGFRA [1] PDGFRA 💬Human cytomegalovirus infection
|
Imatinib mesylate Imatinib mesylate 💬Human cytomegalovirus infection
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬39. Human cytomegalovirus infection
|
||||||||||||||||||||||||||||||||||
40 | Human cytomegalovirus infection 💬 64 genes, 114 drugs (DrugBank) and 130 diseases |
PDGFRA [1] PDGFRA 💬Human cytomegalovirus infection
|
Imatinib Imatinib 💬Human cytomegalovirus infection
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬39. Human cytomegalovirus infection
|
||||||||||||||||||||||||||||||||||
41 | Human cytomegalovirus infection 💬 64 genes, 114 drugs (DrugBank) and 130 diseases |
VEGFA [1] VEGFA 💬Human cytomegalovirus infection
|
Bevacizumab Bevacizumab 💬Human cytomegalovirus infection
| Bevacizumab | 013 [8] 13, 34, 85, 87, 89, 227, 280, 331 💬41. Human cytomegalovirus infection
|
||||||||||||||||||||||||||||||||||
42 | Human papillomavirus infection 💬 51 genes, 106 drugs (DrugBank) and 115 diseases |
VEGFA [1] VEGFA 💬Human papillomavirus infection
|
Bevacizumab Bevacizumab 💬Human papillomavirus infection
| Bevacizumab | 013 [8] 13, 34, 85, 87, 89, 227, 280, 331 💬42. Human papillomavirus infection
|
||||||||||||||||||||||||||||||||||
43 | JAK-STAT signaling pathway 💬 61 genes, 113 drugs (DrugBank) and 123 diseases |
PDGFRA [1] PDGFRA 💬JAK-STAT signaling pathway
|
Imatinib mesylate Imatinib mesylate 💬JAK-STAT signaling pathway
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬43. JAK-STAT signaling pathway
|
||||||||||||||||||||||||||||||||||
44 | JAK-STAT signaling pathway 💬 61 genes, 113 drugs (DrugBank) and 123 diseases |
PDGFRA [1] PDGFRA 💬JAK-STAT signaling pathway
|
Imatinib Imatinib 💬JAK-STAT signaling pathway
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬43. JAK-STAT signaling pathway
|
||||||||||||||||||||||||||||||||||
45 | Kaposi sarcoma-associated herpesvirus infection 💬 60 genes, 94 drugs (DrugBank) and 118 diseases |
VEGFA [1] VEGFA 💬Kaposi sarcoma-associated herpesvirus infection
|
Bevacizumab Bevacizumab 💬Kaposi sarcoma-associated herpesvirus infection
| Bevacizumab | 013 [8] 13, 34, 85, 87, 89, 227, 280, 331 💬45. Kaposi sarcoma-associated herpesvirus infection
|
||||||||||||||||||||||||||||||||||
46 | MAPK signaling pathway 💬 65 genes, 98 drugs (DrugBank) and 109 diseases |
KIT [2] KIT, PDGFRA 💬
|
Imatinib mesylate Imatinib mesylate 💬MAPK signaling pathway
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬46. MAPK signaling pathway
|
||||||||||||||||||||||||||||||||||
47 | MAPK signaling pathway 💬 65 genes, 98 drugs (DrugBank) and 109 diseases |
KIT [2] KIT, PDGFRA 💬
|
Imatinib Imatinib 💬MAPK signaling pathway
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬46. MAPK signaling pathway
|
||||||||||||||||||||||||||||||||||
48 | MAPK signaling pathway 💬 65 genes, 98 drugs (DrugBank) and 109 diseases |
VEGFA [1] VEGFA 💬MAPK signaling pathway
|
Bevacizumab Bevacizumab 💬MAPK signaling pathway
| Bevacizumab | 013 [8] 13, 34, 85, 87, 89, 227, 280, 331 💬48. MAPK signaling pathway
|
||||||||||||||||||||||||||||||||||
49 | Melanogenesis 💬 7 genes, 19 drugs (DrugBank) and 34 diseases |
KIT [1] KIT 💬Melanogenesis
|
Imatinib mesylate Imatinib mesylate 💬Melanogenesis
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬49. Melanogenesis
|
||||||||||||||||||||||||||||||||||
50 | Melanogenesis 💬 7 genes, 19 drugs (DrugBank) and 34 diseases |
KIT [1] KIT 💬Melanogenesis
|
Imatinib Imatinib 💬Melanogenesis
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬49. Melanogenesis
|
||||||||||||||||||||||||||||||||||
51 | Melanoma 💬 17 genes, 34 drugs (DrugBank) and 42 diseases |
PDGFRA [1] PDGFRA 💬Melanoma
|
Imatinib mesylate Imatinib mesylate 💬Melanoma
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬51. Melanoma
|
||||||||||||||||||||||||||||||||||
52 | Melanoma 💬 17 genes, 34 drugs (DrugBank) and 42 diseases |
PDGFRA [1] PDGFRA 💬Melanoma
|
Imatinib Imatinib 💬Melanoma
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬51. Melanoma
|
||||||||||||||||||||||||||||||||||
53 | MicroRNAs in cancer 💬 33 genes, 75 drugs (DrugBank) and 90 diseases |
ABL1 [2] ABL1, PDGFRA 💬
|
Imatinib mesylate Imatinib mesylate 💬MicroRNAs in cancer
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬53. MicroRNAs in cancer
|
||||||||||||||||||||||||||||||||||
54 | MicroRNAs in cancer 💬 33 genes, 75 drugs (DrugBank) and 90 diseases |
ABL1 [2] ABL1, PDGFRA 💬
|
Imatinib Imatinib 💬MicroRNAs in cancer
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬53. MicroRNAs in cancer
|
||||||||||||||||||||||||||||||||||
55 | MicroRNAs in cancer 💬 33 genes, 75 drugs (DrugBank) and 90 diseases |
VEGFA [1] VEGFA 💬MicroRNAs in cancer
|
Bevacizumab Bevacizumab 💬MicroRNAs in cancer
| Bevacizumab | 013 [8] 13, 34, 85, 87, 89, 227, 280, 331 💬55. MicroRNAs in cancer
|
||||||||||||||||||||||||||||||||||
56 | Neurotrophin signaling pathway 💬 22 genes, 29 drugs (DrugBank) and 37 diseases |
ABL1 [1] ABL1 💬Neurotrophin signaling pathway
|
Imatinib mesylate Imatinib mesylate 💬Neurotrophin signaling pathway
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬56. Neurotrophin signaling pathway
|
||||||||||||||||||||||||||||||||||
57 | Neurotrophin signaling pathway 💬 22 genes, 29 drugs (DrugBank) and 37 diseases |
ABL1 [1] ABL1 💬Neurotrophin signaling pathway
|
Imatinib Imatinib 💬Neurotrophin signaling pathway
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬56. Neurotrophin signaling pathway
|
||||||||||||||||||||||||||||||||||
58 | Pancreatic cancer 💬 19 genes, 40 drugs (DrugBank) and 84 diseases |
VEGFA [1] VEGFA 💬Pancreatic cancer
|
Bevacizumab Bevacizumab 💬Pancreatic cancer
| Bevacizumab | 013 [8] 13, 34, 85, 87, 89, 227, 280, 331 💬58. Pancreatic cancer
|
||||||||||||||||||||||||||||||||||
59 | Pathogenic Escherichia coli infection 💬 28 genes, 43 drugs (DrugBank) and 78 diseases |
ABL1 [1] ABL1 💬Pathogenic Escherichia coli infection
|
Imatinib mesylate Imatinib mesylate 💬Pathogenic Escherichia coli infection
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬59. Pathogenic Escherichia coli infection
|
||||||||||||||||||||||||||||||||||
60 | Pathogenic Escherichia coli infection 💬 28 genes, 43 drugs (DrugBank) and 78 diseases |
ABL1 [1] ABL1 💬Pathogenic Escherichia coli infection
|
Imatinib Imatinib 💬Pathogenic Escherichia coli infection
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬59. Pathogenic Escherichia coli infection
|
||||||||||||||||||||||||||||||||||
61 | Pathways in cancer 💬 111 genes, 222 drugs (DrugBank) and 146 diseases |
ABL1 [3] ABL1, KIT, PDGFRA 💬
|
Imatinib mesylate Imatinib mesylate 💬Pathways in cancer
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬61. Pathways in cancer
|
||||||||||||||||||||||||||||||||||
62 | Pathways in cancer 💬 111 genes, 222 drugs (DrugBank) and 146 diseases |
ABL1 [3] ABL1, KIT, PDGFRA 💬
|
Imatinib Imatinib 💬Pathways in cancer
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬61. Pathways in cancer
|
||||||||||||||||||||||||||||||||||
63 | Pathways in cancer 💬 111 genes, 222 drugs (DrugBank) and 146 diseases |
VEGFA [1] VEGFA 💬Pathways in cancer
|
Bevacizumab Bevacizumab 💬Pathways in cancer
| Bevacizumab | 013 [8] 13, 34, 85, 87, 89, 227, 280, 331 💬63. Pathways in cancer
|
||||||||||||||||||||||||||||||||||
64 | Phospholipase D signaling pathway 💬 23 genes, 59 drugs (DrugBank) and 82 diseases |
KIT [2] KIT, PDGFRA 💬
|
Imatinib mesylate Imatinib mesylate 💬Phospholipase D signaling pathway
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬64. Phospholipase D signaling pathway
|
||||||||||||||||||||||||||||||||||
65 | Phospholipase D signaling pathway 💬 23 genes, 59 drugs (DrugBank) and 82 diseases |
KIT [2] KIT, PDGFRA 💬
|
Imatinib Imatinib 💬Phospholipase D signaling pathway
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬64. Phospholipase D signaling pathway
|
||||||||||||||||||||||||||||||||||
66 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
KIT [2] KIT, PDGFRA 💬
|
Imatinib mesylate Imatinib mesylate 💬PI3K-Akt signaling pathway
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬66. PI3K-Akt signaling pathway
|
||||||||||||||||||||||||||||||||||
67 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
KIT [2] KIT, PDGFRA 💬
|
Imatinib Imatinib 💬PI3K-Akt signaling pathway
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬66. PI3K-Akt signaling pathway
|
||||||||||||||||||||||||||||||||||
68 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
VEGFA [1] VEGFA 💬PI3K-Akt signaling pathway
|
Bevacizumab Bevacizumab 💬PI3K-Akt signaling pathway
| Bevacizumab | 013 [8] 13, 34, 85, 87, 89, 227, 280, 331 💬68. PI3K-Akt signaling pathway
|
||||||||||||||||||||||||||||||||||
69 | Prostate cancer 💬 24 genes, 57 drugs (DrugBank) and 89 diseases |
PDGFRA [1] PDGFRA 💬Prostate cancer
|
Imatinib mesylate Imatinib mesylate 💬Prostate cancer
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬69. Prostate cancer
|
||||||||||||||||||||||||||||||||||
70 | Prostate cancer 💬 24 genes, 57 drugs (DrugBank) and 89 diseases |
PDGFRA [1] PDGFRA 💬Prostate cancer
|
Imatinib Imatinib 💬Prostate cancer
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬69. Prostate cancer
|
||||||||||||||||||||||||||||||||||
71 | Proteoglycans in cancer 💬 33 genes, 73 drugs (DrugBank) and 103 diseases |
VEGFA [1] VEGFA 💬Proteoglycans in cancer
|
Bevacizumab Bevacizumab 💬Proteoglycans in cancer
| Bevacizumab | 013 [8] 13, 34, 85, 87, 89, 227, 280, 331 💬71. Proteoglycans in cancer
|
||||||||||||||||||||||||||||||||||
72 | Rap1 signaling pathway 💬 45 genes, 113 drugs (DrugBank) and 98 diseases |
KIT [2] KIT, PDGFRA 💬
|
Imatinib mesylate Imatinib mesylate 💬Rap1 signaling pathway
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬72. Rap1 signaling pathway
|
||||||||||||||||||||||||||||||||||
73 | Rap1 signaling pathway 💬 45 genes, 113 drugs (DrugBank) and 98 diseases |
KIT [2] KIT, PDGFRA 💬
|
Imatinib Imatinib 💬Rap1 signaling pathway
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬72. Rap1 signaling pathway
|
||||||||||||||||||||||||||||||||||
74 | Rap1 signaling pathway 💬 45 genes, 113 drugs (DrugBank) and 98 diseases |
VEGFA [1] VEGFA 💬Rap1 signaling pathway
|
Bevacizumab Bevacizumab 💬Rap1 signaling pathway
| Bevacizumab | 013 [8] 13, 34, 85, 87, 89, 227, 280, 331 💬74. Rap1 signaling pathway
|
||||||||||||||||||||||||||||||||||
75 | Ras signaling pathway 💬 37 genes, 64 drugs (DrugBank) and 70 diseases |
ABL1 [3] ABL1, KIT, PDGFRA 💬
|
Imatinib mesylate Imatinib mesylate 💬Ras signaling pathway
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬75. Ras signaling pathway
|
||||||||||||||||||||||||||||||||||
76 | Ras signaling pathway 💬 37 genes, 64 drugs (DrugBank) and 70 diseases |
ABL1 [3] ABL1, KIT, PDGFRA 💬
|
Imatinib Imatinib 💬Ras signaling pathway
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬75. Ras signaling pathway
|
||||||||||||||||||||||||||||||||||
77 | Ras signaling pathway 💬 37 genes, 64 drugs (DrugBank) and 70 diseases |
VEGFA [1] VEGFA 💬Ras signaling pathway
|
Bevacizumab Bevacizumab 💬Ras signaling pathway
| Bevacizumab | 013 [8] 13, 34, 85, 87, 89, 227, 280, 331 💬77. Ras signaling pathway
|
||||||||||||||||||||||||||||||||||
78 | Regulation of actin cytoskeleton 💬 35 genes, 82 drugs (DrugBank) and 81 diseases |
PDGFRA [1] PDGFRA 💬Regulation of actin cytoskeleton
|
Imatinib mesylate Imatinib mesylate 💬Regulation of actin cytoskeleton
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬78. Regulation of actin cytoskeleton
|
||||||||||||||||||||||||||||||||||
79 | Regulation of actin cytoskeleton 💬 35 genes, 82 drugs (DrugBank) and 81 diseases |
PDGFRA [1] PDGFRA 💬Regulation of actin cytoskeleton
|
Imatinib Imatinib 💬Regulation of actin cytoskeleton
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬78. Regulation of actin cytoskeleton
|
||||||||||||||||||||||||||||||||||
80 | Relaxin signaling pathway 💬 23 genes, 34 drugs (DrugBank) and 51 diseases |
VEGFA [1] VEGFA 💬Relaxin signaling pathway
|
Bevacizumab Bevacizumab 💬Relaxin signaling pathway
| Bevacizumab | 013 [8] 13, 34, 85, 87, 89, 227, 280, 331 💬80. Relaxin signaling pathway
|
||||||||||||||||||||||||||||||||||
81 | Renal cell carcinoma 💬 12 genes, 16 drugs (DrugBank) and 26 diseases |
VEGFA [1] VEGFA 💬Renal cell carcinoma
|
Bevacizumab Bevacizumab 💬Renal cell carcinoma
| Bevacizumab | 013 [8] 13, 34, 85, 87, 89, 227, 280, 331 💬81. Renal cell carcinoma
|
||||||||||||||||||||||||||||||||||
82 | Rheumatoid arthritis 💬 38 genes, 59 drugs (DrugBank) and 87 diseases |
VEGFA [1] VEGFA 💬Rheumatoid arthritis
|
Bevacizumab Bevacizumab 💬Rheumatoid arthritis
| Bevacizumab | 013 [8] 13, 34, 85, 87, 89, 227, 280, 331 💬82. Rheumatoid arthritis
|
||||||||||||||||||||||||||||||||||
83 | VEGF signaling pathway 💬 23 genes, 56 drugs (DrugBank) and 94 diseases |
VEGFA [1] VEGFA 💬VEGF signaling pathway
|
Bevacizumab Bevacizumab 💬VEGF signaling pathway
| Bevacizumab | 013 [8] 13, 34, 85, 87, 89, 227, 280, 331 💬83. VEGF signaling pathway
|
||||||||||||||||||||||||||||||||||
84 | Viral myocarditis 💬 34 genes, 27 drugs (DrugBank) and 52 diseases |
ABL1 [1] ABL1 💬Viral myocarditis
|
Imatinib mesylate Imatinib mesylate 💬Viral myocarditis
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬84. Viral myocarditis
|
||||||||||||||||||||||||||||||||||
85 | Viral myocarditis 💬 34 genes, 27 drugs (DrugBank) and 52 diseases |
ABL1 [1] ABL1 💬Viral myocarditis
|
Imatinib Imatinib 💬Viral myocarditis
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬84. Viral myocarditis
|
Acute myeloid leukemia
18 genes, 37 drugs (DrugBank) and 71 diseases
AGE-RAGE signaling pathway in diabetic complications
28 genes, 55 drugs (DrugBank) and 96 diseases
Axon guidance
22 genes, 26 drugs (DrugBank) and 75 diseases
Bladder cancer
11 genes, 27 drugs (DrugBank) and 33 diseases
Breast cancer
22 genes, 63 drugs (DrugBank) and 80 diseases
Calcium signaling pathway
86 genes, 214 drugs (DrugBank) and 143 diseases
Cell cycle
11 genes, 12 drugs (DrugBank) and 25 diseases
Central carbon metabolism in cancer
19 genes, 37 drugs (DrugBank) and 65 diseases
Chemical carcinogenesis - reactive oxygen species
25 genes, 39 drugs (DrugBank) and 51 diseases
Chemical carcinogenesis - receptor activation
39 genes, 135 drugs (DrugBank) and 134 diseases
Choline metabolism in cancer
11 genes, 30 drugs (DrugBank) and 61 diseases
Chronic myeloid leukemia
17 genes, 23 drugs (DrugBank) and 36 diseases
Endocytosis
22 genes, 37 drugs (DrugBank) and 54 diseases
ErbB signaling pathway
14 genes, 28 drugs (DrugBank) and 62 diseases
Fluid shear stress and atherosclerosis
34 genes, 59 drugs (DrugBank) and 93 diseases
Focal adhesion
31 genes, 51 drugs (DrugBank) and 52 diseases
Gap junction
26 genes, 97 drugs (DrugBank) and 82 diseases
Glioma
15 genes, 34 drugs (DrugBank) and 64 diseases
Hematopoietic cell lineage
53 genes, 95 drugs (DrugBank) and 101 diseases
HIF-1 signaling pathway
26 genes, 56 drugs (DrugBank) and 87 diseases
Human cytomegalovirus infection
64 genes, 114 drugs (DrugBank) and 130 diseases
Human papillomavirus infection
51 genes, 106 drugs (DrugBank) and 115 diseases
JAK-STAT signaling pathway
61 genes, 113 drugs (DrugBank) and 123 diseases
Kaposi sarcoma-associated herpesvirus infection
60 genes, 94 drugs (DrugBank) and 118 diseases
MAPK signaling pathway
65 genes, 98 drugs (DrugBank) and 109 diseases
Melanogenesis
7 genes, 19 drugs (DrugBank) and 34 diseases
Melanoma
17 genes, 34 drugs (DrugBank) and 42 diseases
MicroRNAs in cancer
33 genes, 75 drugs (DrugBank) and 90 diseases
Neurotrophin signaling pathway
22 genes, 29 drugs (DrugBank) and 37 diseases
Pancreatic cancer
19 genes, 40 drugs (DrugBank) and 84 diseases
Pathogenic Escherichia coli infection
28 genes, 43 drugs (DrugBank) and 78 diseases
Pathways in cancer
111 genes, 222 drugs (DrugBank) and 146 diseases
Phospholipase D signaling pathway
23 genes, 59 drugs (DrugBank) and 82 diseases
PI3K-Akt signaling pathway
85 genes, 142 drugs (DrugBank) and 131 diseases
Prostate cancer
24 genes, 57 drugs (DrugBank) and 89 diseases
Proteoglycans in cancer
33 genes, 73 drugs (DrugBank) and 103 diseases
Rap1 signaling pathway
45 genes, 113 drugs (DrugBank) and 98 diseases
Ras signaling pathway
37 genes, 64 drugs (DrugBank) and 70 diseases
Regulation of actin cytoskeleton
35 genes, 82 drugs (DrugBank) and 81 diseases
Relaxin signaling pathway
23 genes, 34 drugs (DrugBank) and 51 diseases
Renal cell carcinoma
12 genes, 16 drugs (DrugBank) and 26 diseases
Rheumatoid arthritis
38 genes, 59 drugs (DrugBank) and 87 diseases
VEGF signaling pathway
23 genes, 56 drugs (DrugBank) and 94 diseases
Viral myocarditis
34 genes, 27 drugs (DrugBank) and 52 diseases